NTBL Bathi pungkasan Notable Labs Ltd

The biotechnology platform Notable Labs, Ltd. (NTBL) demonstrates macro resilience, as the fight against oncology is not subject to seasonality. The company's financial performance history on this GURU.Markets chart shows that 0.00 determines the current value of the indicator. Personalized blood cancer therapy selection minimizes risks, while attracting AI experts through stock options ensures the staffing stability of the laboratories.

NTBL (Notable Labs, Ltd.) riwayat Bathi resik saka 21.02.2024 nganti 02.11.2024

Rincian analitis lan laporan data perusahaan Notable Labs (NTBL)

- nilai saham lan prakiraan konsensus rega:

Rega bursa Notable Labs Corp|NTBL - Bagan rega target

- data kapitalisasi pasar:

Nilai pasar Notable Labs Corp|NTBL - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- rincian valuasi buku bisnis:

Nilai Akuntansi Saham Notable Labs|NTBL - Kapitalisasi Buku|Rasio Kapitalisasi marang Aset Bersih notablelabs.com|NTBL - Gunggung Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Total Utang marang Modal Notable Labs, Ltd.|NTBL - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Notable Labs Ltd|NTBL - Gunggung utang perusahaan|Utang-utang marang nilai buku Notable Labs Corp|NTBL - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Notable Labs|Likuiditas darurat notablelabs.com

- indikator pendapatan resik lan kelipatan nilai:

NTBL - Penghasilan resik

Pambiji fundamental:NTBL Notable Labs Corp

Profit reflects the final financial result after deducting all operating and tax expenses, allowing the investor to assess the actual efficiency of cash flow generation. Analyzing the net economic effect of Notable Labs, Ltd. (NTBL) on the GURU.Markets platform, one can observe how geopolitical fragmentation and reagent supply disruptions for Notable Labs, Ltd. (NTBL) limit the scaling of clinical trials, directly impacting the business's bottom-line profitability.

Pesaing utama